Predictive markers of everolimus efficacy in hormone receptor positive (HR+) metastatic breast cancer (MBC): Final results of the TAMRAD trial translational study.
暂无分享,去创建一个
D. Spaeth | I. Treilleux | T. Bachelot | M. Arnedos | J. Ferrero | E. Pujade-Lauraine | C. Lévy | E. Legouffe | C. Cropet | S. A. Lacourtoisie | Quing Wang